国际肿瘤学杂志››2014,Vol. 41››Issue (11): 837-840.doi:10.3760/cma.j.issn.1673-422X.2014.11.012
出版日期:
2014-12-03发布日期:
2015-01-20通讯作者:
黄新余,Email: 18930177490@163.com
Online:
2014-12-03Published:
2015-01-20Contact:
Huang Xinyu, Email: 18930177490@163.com摘要:微小RNA(miRNA)在基因表达的翻译阶段发挥调节作用,现已发现miRNA直接参与胰腺癌的发生、发展,其表达异常与胰腺癌的早期诊断密切相关,同时可能为胰腺癌患者提供新的治疗靶点。临床检测miRNA将会在胰腺癌诊断治疗领域有良好的应用前景。
孟庆才, 古宏晨, 黄新余. 微小RNA在胰腺癌诊疗中的研究进展[J]. 国际肿瘤学杂志, 2014, 41(11): 837-840.
MENG Qing-Cai, GU Hong-Chen, HUANG Xin-Yu. Research progress of microRNA in diagnosis and treatment of pancreatic cancer[J]. Journal of International Oncology, 2014, 41(11): 837-840.
[1] Ferlay J, SteliarovaFoucher E, LortetTieulent J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012[J]. Eur J Cancer, 2013, 49(6):13741403. [2] Hidalgo M. Pancreatic cancer[J]. N Engl J Med, 2010, 362(17):16051617. [3] Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013[J]. CA Cancer J Clin, 2013, 63(1):1130. [4] Bauer AS, Keller A, Costello E, et al. Diagnosis of pancreatic ductal adenocarcinoma and chronic pancreatitis by measurement of microRNA abundance in blood and tissue[J]. PLoS One, 2012, 7(4):e34151. [5] Bloomston M, Frankel WL, Petrocca F, et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis[J]. JAMA, 2007, 297(17):19011908. [6] Schultz NA, Werner J, Willenbrock H, et al. MicroRNA expression profiles associated with pancreatic adenocarcinoma and ampullary adenocarcinoma[J]. Mod Pathol, 2012, 25(12):16091622. [7] Farazi TA, Spitzer JI, Morozov P, et al. miRNAs in human cancer[J]. J Pathol, 2011, 223(2):102115. [8] Iorio MV, Croce CM. MicroRNAs in cancer: small molecules with a huge impact[J]. J Clin Oncol, 2009, 27(34):58485856. [9] Ambros V. The functions of animal microRNAs[J]. Nature, 2004, 431(7006):350355. [10] Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function[J]. Cell, 2004, 116(2):281297. [11] Giovinazzo F, Turri G, Zanini S, et al. Clinical implications of biological markers in pancreatic ductal adenocarcinoma[J]. Surg Oncol, 2012, 21(4):e171182. [12] Kaur S, Baine MJ, Jain M, et al. Early diagnosis of pancreatic cancer: challenges and new developments[J]. Biomark Med, 2012, 6(5):597612. [13] Panarelli NC, Chen YT, Zhou XK, et al. MicroRNA expression aids the preoperative diagnosis of pancreatic ductal adenocarcinoma[J]. Pancreas, 2012, 41(5):685690. [14] Zhang Y, Li M, Wang H, et al. Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by realtime PCR analysis[J]. World J Surg, 2009, 33(4):698709. [15] Chen X, Ba Y, Ma L, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases[J]. Cell Res, 2008, 18(10):9971006. [16] Wang J, Chen J, Chang P, et al. MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel bloodbased biomarkers of disease[J]. Cancer Prev Res, 2009, 2(9):807813. [17] Ali S, Almhanna K, Chen W, et al. Differentially expressed miRNAs in the plasma may provide a molecular signature for aggressive pancreatic cancer[J]. Am J Transl Res, 2010, 3(1):2847. [18] Liu J, Gao J, Du Y, et al. Combination of plasma microRNAs with serum CA199 for early detection of pancreatic cancer[J]. Int J Cancer, 2012, 131(3):683691. [19] Liu R, Chen X, Du Y, et al. Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer[J]. Clin Chem, 2012, 58(3):610618. [20] Sadakari Y, Ohtsuka T, Ohuchida K, et al. MicroRNA expression analyses in preoperative pancreatic juice samples of pancreatic ductal adenocarcinoma[J]. JOP, 2010, 11(6): 587592. [21] Schultz NA, Dehlendorff C, Jensen BV, et al. MicroRNA biomarkers in whole blood for detection of pancreatic cancer[J]. JAMA, 2014, 311(4): 392404. [22] Wang WS, Liu LX, Li GP, et al. Combined serum CA199 and miR27a3p in peripheral blood mononuclear cells to diagnose pancreatic cancer[J]. Cancer Prev Res, 2013, 6(4):331338. [23] Jones S, Zhang X, Parsons DW, et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses[J]. Science, 2008, 321(5897):18011806. [24] Mahadevan D, Chalasani P, Rensvold D, et al. Phase Ⅰ trial of AEG35156 an antisense oligonucleotide to XIAP plus gemcitabine in patients with metastatic pancreatic ductal adenocarcinoma[J]. Am J Clin Oncol, 2013, 36(3):239243. [25] Parasramka MA, Ali S, Banerjee S, et al. Garcinol sensitizes human pancreatic adenocarcinoma cells to gemcitabine in association with microRNA signatures[J]. Mol Nutr Food Res, 2013, 57(2):235248. [26] Ji Q, Hao X, Zhang M, et al. MicroRNA miR34 inhibits human pancreatic cancer tumorinitiating cells[J]. PLoS One, 2009, 4(8):e6816. [27] Pramanik D, Campbell NR, Karikari C, et al. Restitution of tumor suppressor microRNAs using a systemic nanovector inhibits pancreatic cancer growth in mice[J]. Mol Cancer Ther, 2011, 10(8):14701480. |
[1] | 刘娜, 寇介丽, 杨枫, 刘桃桃, 李丹萍, 韩君蕊, 杨立洲.血清miR-106b-5p、miR-760联合低剂量螺旋CT诊断早期肺癌的临床价值[J]. 国际肿瘤学杂志, 2024, 51(6): 321-325. |
[2] | 钱晓涛, 石子宜, 胡格, 吴晓维.Ⅲ~ⅣA期食管鳞状细胞癌放化疗后行巩固化疗的疗效:一项真实世界临床研究[J]. 国际肿瘤学杂志, 2024, 51(6): 326-331. |
[3] | 杨蜜, 别俊, 张加勇, 邓佳秀, 唐组阁, 卢俊.局部晚期可切除食管癌新辅助治疗疗效及预后分析[J]. 国际肿瘤学杂志, 2024, 51(6): 332-337. |
[4] | 袁健, 黄燕华.Hp-IgG抗体联合血清DKK1、sB7-H3对早期胃癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(6): 338-343. |
[5] | 张百红, 岳红云.新作用机制的抗肿瘤药物进展[J]. 国际肿瘤学杂志, 2024, 51(6): 354-358. |
[6] | 许凤琳, 吴刚.EBV在鼻咽癌肿瘤免疫微环境和免疫治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 359-363. |
[7] | 王盈, 刘楠, 郭兵.抗体药物偶联物在转移性乳腺癌治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 364-369. |
[8] | 张宁宁, 杨哲, 檀丽梅, 李振宁, 王迪, 魏永志.宫颈细胞DNA倍体分析联合B7-H4和PKCδ对宫颈癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(5): 286-291. |
[9] | 陈琦, 徐晨阳, 王寅, 雷大鹏.高光谱成像在头颈部肿瘤诊疗中的应用现状[J]. 国际肿瘤学杂志, 2024, 51(5): 298-302. |
[10] | 王培鑫, 赵军, 徐世红, 姜朝阳, 王小强, 杨红娟.铁死亡相关机制在骨肉瘤中的应用进展[J]. 国际肿瘤学杂志, 2024, 51(5): 308-311. |
[11] | 张洁, 范玲, 李杰, 温华, 苏媛媛, 路宁, 张明鑫.原发性胰腺淋巴瘤1例并文献复习[J]. 国际肿瘤学杂志, 2024, 51(5): 316-320. |
[12] | 王昆, 周中新, 臧其威.血清TGF-β1、VEGF水平对非小细胞肺癌患者单孔胸腔镜根治术后复发的预测价值[J]. 国际肿瘤学杂志, 2024, 51(4): 198-203. |
[13] | 萨蔷, 徐航程, 王佳玉.乳腺癌免疫治疗研究进展[J]. 国际肿瘤学杂志, 2024, 51(4): 227-234. |
[14] | 杨智, 陆以乔, 顾花艳, 丁佳玲, 郭贵龙.肿瘤微环境介导乳腺癌靶向治疗耐药的研究进展[J]. 国际肿瘤学杂志, 2024, 51(4): 235-238. |
[15] | 王子豪, 王宇, 杨鑫, 何艺, 莫兴奎, 袁涛.铁死亡在骨肉瘤中的分子机制及相关治疗的研究进展[J]. 国际肿瘤学杂志, 2024, 51(4): 239-244. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||